Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the use and potential FDA Approval of adding methotrexate to KRYSTEXXA(pegloticase) in patients with uncontrolled gout

Ticker(s): HZNP

Who's the expert?

Institution: Rowan Diagnostic Clinic

Board certified Rheumatologist
prescribed Krystexxa for ~20 uncontrolled gout patients and is very familiar with the MIRROR trial data.
currently working on an ongoing phase 4 trial with Krystexxa

Interview Goal

Digging in to the potential of immunomodulators, like methotrexate, in cases of refractory gout where Krystexxa is prescribed. We will also cover the MIRROR trial study design and data as well as taking a look at the upcoming sBLA of methotrexate with Krystexxa on July 7th

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.